Longboard Pharmaceuticals Inc (LBPH)

followers · Follow

Sector:

HEALTH CARE

Industry:

BIOTECHNOLOGY & LIFE SCIENCES

CEO:

Kevin R. Lind

Employees:

4275 EXECUTIVE SQUARE, SUITE 950, LA JOLLA, CA, 92037

619-592-9775

longboardpharma.com

Longboard Pharmaceuticals, Inc. focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies.

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

Longboard Pharmaceuticals Inc YCharts
Yahoo! Finance	finviz

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available